SAN DIEGO--(BUSINESS WIRE)--Ascenta Therapeutics, Inc. announced today that its small molecule portfolio of apoptosis-triggering compounds will be featured in two oral presentations and several poster presentations this week at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, being held October 22-26, 2007 at the Moscone Convention Center in San Francisco, CA.
